Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-17

FDA Approved: BOSENTAN — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for bosentan filed by Actavis Pharma, Inc. to authorize the continued marketing of the generic product. This action conf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bosentan (Bosentan)

Snippet

SUPPL AP for BOSENTAN (BOSENTAN)